FDA Inspection
Sircle Laboratories, L.L.C.Sircle Laboratories, L.L.C. – FDA Inspection, Mar 19, 2019
Record Details
This FDA Inspection record concerns Sircle Laboratories, L.L.C., with an inspection on March 19, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 590b8e25-4b92-4d95-a841-ab7849121390
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1083116
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.198(b)Written complaint record to be maintained at facility
- 21 CFR 211.22(a)Contract drug products--lack of responsibility
- 21 CFR 211.122(a)Written procedures describing in detail
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sircle Laboratories, L.L.C.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sircle Laboratories, L.L.C.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.